Cargando…

Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names

INTRODUCTION: The purpose of the present study was to investigate the traceability of adverse events (AEs) for branded and generic drugs with identical nonproprietary names and to consider potential implications for the traceability of AEs for branded and biosimilar biologics. METHODS: Adverse event...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chao, Jingdong, Skup, Martha, Alexander, Emily, Tundia, Namita, Macaulay, Dendy, Wu, Eric, Mulani, Parvez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376954/ https://www.ncbi.nlm.nih.gov/pubmed/25772256 http://dx.doi.org/10.1007/s12325-015-0193-5

Ejemplares similares

International nonproprietary names for monoclonal antibodies: an evolving nomenclature system
por: Guimaraes Koch, Sofia S., et al.
Publicado: (2022)

Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names
por: Bryan, Rachel, et al.
Publicado: (2015)

The INNs and outs of antibody nonproprietary names
por: Jones, Tim D., et al.
Publicado: (2015)

Direct and indirect resource use, healthcare costs and work force absence in patients with non‐infectious intermediate, posterior or panuveitis
por: Thorne, Jennifer E., et al.
Publicado: (2016)

Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis
por: Strand, Vibeke, et al.
Publicado: (2018)

International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety
por: Robertson, James S., et al.
Publicado: (2022)

Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more
por: Parren, Paul W. H. I., et al.
Publicado: (2017)

The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough
por: Loizides, Ursula, et al.
Publicado: (2021)

The Impact of International Nonproprietary Names Integration on Prescribing Reimbursement Medicines for Arterial Hypertension and Analysis of Medication Errors in Latvia
por: Gavrilova, Anna, et al.
Publicado: (2022)

Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names
por: Wilkinson, Ian, et al.
Publicado: (2022)

International nonproprietary names (INN) for pharmaceuticals substances : lists 1-73 of proposed INN and lists 1-35 of recomended INN cumulative list No. 9 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-73 de DCI proposées et listes 1-35 de DCI recommandées liste récapitulative No. 9
Publicado: (1996)

International nonproprietary names (INN) for pharmaceutical substances, : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques, listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Publicado: (1992)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Publicado: (1992)

The Naming of Names: Guidelines for Gene Nomenclature in Marchantia
por: Bowman, John L., et al.
Publicado: (2016)

Biosimilars: The naming puzzle
por: Gaur, Rajneesh Kumar
Publicado: (2015)

International nonproprietary names (INN) for pharmaceutical substances, 1988 : lists 1-58 of proposed INN and lists 1-27 of recommended INN : cumulative list no. 7 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques, 1988 : listes 1-58 de DCI proposées et listes 1-27 de DCI recommandées : liste récapitulative no. 7.
Publicado: (1988)

International nonproprietary names (INN) for pharmaceutical substances, 1982 : lists 1-47 of proposed INN and lists 1-21 of recommended INN : cumulative list no. 6 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques, 1982 : listes 1-47 de DCI proposées et listes 1-21 de DCI recommandées : liste récapitulative no. 6.
Publicado: (1982)

How to Lend Money: If You Lend at All
Publicado: (1856)

How to Lend Money: If You Lend at All
Publicado: (1878)

How to Lend Money, If You Lend at All
Publicado: (1885)

“Pseudo” Nomenclature in Dermatology: What's in a Name?
por: Ghosh, Sangita, et al.
Publicado: (2013)

LPSN—list of prokaryotic names with standing in nomenclature
por: Parte, Aidan C.
Publicado: (2014)

Microbial nomenclature: A list of names and origins
por: Berger, Stephen A., et al.
Publicado: (1987)

New Phylum Names Harmonize Prokaryotic Nomenclature
por: Oren, Aharon, et al.
Publicado: (2022)

Fungal Nomenclature: Managing Change is the Name of the Game
por: Kidd, Sarah E, et al.
Publicado: (2023)

Fungal Nomenclature: Managing Change Is the Name of the Game
por: Denning, David W
Publicado: (2023)

Debate: The slippery slope of surrogate outcomes
por: D'Agostino, Ralph B
Publicado: (2000)

Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod
por: Correale, Jorge, et al.
Publicado: (2016)

BMP Debate: evidence in the name of science?
Publicado: (2011)

Nomenclatural considerations in naming species of Aspergillus and its teleomorphs
por: Pitt, J.I., et al.
Publicado: (2007)

Biological nomenclature terms for facilitating communication in the naming of organisms
por: David, John, et al.
Publicado: (2012)

There's something about that name: Nomenclature of anomalous coronary arteries
por: Harikrishnan, S.
Publicado: (2015)

Auditory Nomenclature: Combining Name Recognition With Anatomical Description
por: Fritzsch, Bernd, et al.
Publicado: (2018)

Knowing and Naming: Phage Annotation and Nomenclature for Phage Therapy
por: Grigson, Susanna R, et al.
Publicado: (2023)

Sherborn’s Index Animalium: New names, systematic errors and availability of names in the light of modern nomenclature
por: Welter-Schultes, Francisco, et al.
Publicado: (2016)

The rose and the name: the unresolved debate on biotechnological terms
por: Domínguez, Martí, et al.
Publicado: (2019)

The Protein Naming Utility: a rules database for protein nomenclature
por: Goll, Johannes, et al.
Publicado: (2010)

What’s in a Name? Exploring the Nomenclature of Science Communication in the UK
por: Illingworth, Sam, et al.
Publicado: (2015)

List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
por: Parte, Aidan C., et al.
Publicado: (2020)

Nomenclatural notes and typification of nine names related to Jasminum (Oleaceae)
por: Quang, Bui Hong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_siqskavrjid7irij3uomq02d2h